Antiretroviral therapy coverage for PMTCT in Costa Rica
Costa Rica: Antiretroviral therapy coverage for PMTCT was 42.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Costa Rica, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in Costa Rica stood at 42.0%.
The figure is down 50.0% on the previous year and down 17.6% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Costa Rica peaked at 100.0% in 2018 and was at its lowest, 0.0%, in 2000.
That places Costa Rica 70th out of 84 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Costa Rica, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 6.0% | — |
| 2002 | 12.0% | +100.0% |
| 2003 | 18.0% | +50.0% |
| 2004 | 24.0% | +33.3% |
| 2005 | 30.0% | +25.0% |
| 2006 | 36.0% | +20.0% |
| 2007 | 39.0% | +8.3% |
| 2008 | 39.0% | +0.0% |
| 2009 | 41.0% | +5.1% |
| 2013 | 43.0% | +4.9% |
| 2014 | 51.0% | +18.6% |
| 2015 | 87.0% | +70.6% |
| 2016 | 88.0% | +1.1% |
| 2017 | 98.0% | +11.4% |
| 2018 | 100.0% | +2.0% |
| 2019 | 100.0% | +0.0% |
| 2020 | 83.0% | -17.0% |
| 2021 | 100.0% | +20.5% |
| 2022 | 43.0% | -57.0% |
| 2023 | 84.0% | +95.3% |
| 2024 | 42.0% | -50.0% |
Costa Rica compared with similar countries
- Costa Rica's 42.0% is below the median for high income countries, which is 89.0%, 47% of the median. (8 countries reporting)
- Costa Rica's 42.0% is below the median for Latin America & Caribbean, which is 68.0%, 62% of the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 24.5% | 0.0% | 41.0% | 10 |
| 2010s | 81.0% | 43.0% | 100.0% | 7 |
| 2020s | 70.4% | 42.0% | 100.0% | 5 |
Countries ranked near Costa Rica
More health data for Costa Rica
- Un projection of annual infant deaths, annual growth rate -2.78 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4617 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,632 deaths per 1,000 people (2090)
- Number of infants who die before age 1 35 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.42 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0248 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.37 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Costa Rica?
- Antiretroviral therapy coverage for pmtct in Costa Rica was 42.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Costa Rica?
- The highest recorded value was 100.0% in 2018.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Costa Rica?
- The lowest recorded value was 0.0% in 2000.
- How does Costa Rica rank for antiretroviral therapy coverage for pmtct?
- Costa Rica ranks 70th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Costa Rica?
- Over the last ten years it is down 17.6%. The long-run trend across the full record is volatile.
- Where does this Costa Rica data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).